Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Boehringer Ingelheim
US Department of Justice
UBS
McKesson
Citi
Harvard Business School
Farmers Insurance
Chubb

Generated: May 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019937

« Back to Dashboard

NDA 019937 describes ADENOCARD, which is a drug marketed by Astellas and is included in one NDA. It is available from two suppliers. Additional details are available on the ADENOCARD profile page.

The generic ingredient in ADENOCARD is adenosine. There are twenty-six drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the adenosine profile page.
Summary for 019937
Tradename:ADENOCARD
Applicant:Astellas
Ingredient:adenosine
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 019937
Mechanism of ActionAdenosine Receptor Agonists
Medical Subject Heading (MeSH) Categories for 019937
Suppliers and Packaging for NDA: 019937
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ADENOCARD adenosine INJECTABLE;INJECTION 019937 NDA Astellas Pharma US, Inc. 0469-8234 N 0469-8234-12
ADENOCARD adenosine INJECTABLE;INJECTION 019937 NDA Astellas Pharma US, Inc. 0469-8234 N 0469-8234-14

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength3MG/ML
Approval Date:Oct 30, 1989TE:APRLD:Yes

Expired US Patents for NDA 019937

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astellas ADENOCARD adenosine INJECTABLE;INJECTION 019937-002 Oct 30, 1989 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Healthtrust
Teva
Fish and Richardson
Harvard Business School
Dow
Boehringer Ingelheim
Cantor Fitzgerald
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.